CJC-1295 / Ipamorelin 5mg/5mg

CJC-1295 (with or without DAC) and Ipamorelin are growth hormone–modulating peptides that have been investigated in research settings for their interaction with endogenous growth hormone (GH) and insulin-like growth factor-1 (IGF-1) signaling pathways.

Preclinical and experimental models have evaluated their potential influence on:

• Body composition parameters
• Recovery-associated biological processes
• Metabolic regulation pathways
• Sleep-related hormonal rhythms

Scientific interest centers on their combined ability to engage distinct mechanisms involved in growth hormone release dynamics. Available data remain early-stage and dependent on study design, dosing structure, and research conditions.

These compounds are not approved by the U.S. Food and Drug Administration. They are supplied strictly for laboratory, research, and educational purposes under the supervision of appropriately licensed professionals. Not intended for human consumption.